
High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
Organic solvent, pH, salt concentration, and gradient mixing rates influence HIC separations. Optimizing these factors allows for effective separation of mAbs and ADCs.





